Jaguar Health (JAGX) Capital Expenditures (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Capital Expenditures of -$37000.0 for Q1 2026, up 96.98% quarter-over-quarter from -$1.2 million in Q4 2025.
Jaguar Health (JAGX) Capital Expenditures (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Capital Expenditures for 12 consecutive years, with -$37000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures changed N/A year-over-year to -$37000.0; the TTM figure through Mar 2026 stood at -$1.4 million (changed N/A YoY), while the FY2025 annual figure was -$1.2 million, down 7431.25% from the prior year.
- Capital Expenditures climbed to -$37000.0 in Q1 2026 per JAGX's latest filing, from -$1.2 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.2 million in Q2 2022 and bottomed at -$1.3 million in Q4 2022.
- Historically, Capital Expenditures has averaged -$66266.7 across 5 years, with a median of $4000.0 in 2023.
- On a YoY basis, Capital Expenditures climbed as much as 37650.0% in 2024 and fell as far as 10400.0% in 2024.
- Jaguar Health's Capital Expenditures stood at -$1.3 million in 2022, then soared by 99.77% to -$3000.0 in 2023, then plunged by 10400.0% to -$315000.0 in 2024, then slumped by 289.52% to -$1.2 million in 2025, then surged by 96.98% to -$37000.0 in 2026.
- Business Quant data shows JAGX's Capital Expenditures at -$37000.0 in Q1 2026, -$1.2 million in Q4 2025, and $160000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | -37,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37,000.00 |
| Mar 31, 2026 | -37,000.00 |
| Dec 31, 2025 | -1.23 Mn |
| Dec 31, 2025 | -1.23 Mn |
| Sep 30, 2025 | 160,000.00 |
| Sep 30, 2025 | 160,000.00 |
| Dec 31, 2024 | -315,000.00 |
| Dec 31, 2024 | -315,000.00 |
| Sep 30, 2024 | 315,000.00 |
| Sep 30, 2024 | 315,000.00 |
| Jun 30, 2024 | 751,000.00 |
| Jun 30, 2024 | 751,000.00 |
| Mar 31, 2024 | -735,000.00 |
| Mar 31, 2024 | -735,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -2,000.00 |